Effect of an acute dose of omega-3 ﬁsh oil following exercise-induced muscle damage by Jakeman, John R. et al.
Eﬀect of an acute dose of omega-3 ﬁsh oil 
following exercise-induced muscle damage 
 
 
Jakeman, J. R. 
Lambrick, D. M. 
Wooley, B. 
Babraj, John A. 
Faulkner, J. A. 
 
 
 
 
The final publication is available at Springer via 
https://dx.doi.org/10.1007/s00421-017-3543-y 
 
  
Effect of an acute dose of omega-3 fish oil following exercise-induced muscle damage 
J.R. Jakeman1, D.M. Lambrick2, B. Wooley3, J.A. Babraj4, J.A. Faulkner5 
1 Department of Sport and Health Science, Oxford Brookes University, Oxford, OX3 0BP, UK 
2 Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ, UK 
3 School of Sport and Exercise, Massey University, Wellington, 6140, New Zealand 
4 Division of Sport and Exercise Science, University of Abertay, Dundee, DD1 1HG, UK 
5 Department of Sport and Exercise, University of Winchester, Winchester SO22 4NR, UK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
Purpose The purpose of this double-blind, placebocontrolled study was to examine the effect of two 
fish oil supplements, one high in EPA (750 mg EPA, 50 mg DHA) and one low in EPA (150 mg EPA, 100 
mg DHA), taken acutely as a recovery strategy following EIMD. 
Methods Twenty-seven physically active males (26 ± 4 year, 1.77 ± 0.07 m, 80 ± 10 kg) completed 
100 plyometric drop jumps to induce muscle damage. Perceptual (perceived soreness) and 
functional (isokinetic muscle strength at 60° and 180° s−1, squat jump performance and 
countermovement jump performance) indices of EIMD were recorded before, and 1, 24, 48, 72, and 
96h after the damaging protocol. Immediately after the damaging protocol, volunteers ingested 
either a placebo (Con), a low-EP fish oil (Low EPA) or a high-EPA fish oil (High EPA) at a dose of 1 g 
per 10 kg body mass. 
Results A significant group main effect was observed for squat jump, with the High EPA group 
performing better than Con and Low EPA groups (average performance decrement, 2.1, 8.3 and 
9.8%, respectively), and similar findings were observed for countermovement jump performance, 
(average performance decrement, 1.7, 6.8 and 6.8%, respectively, p = 0.07). Significant time, but no 
interaction main effects were observed for all functional and perceptual indices measured, although 
large effect sizes demonstrate a possible ameliorating effect of high dose of EPA fish 
supplementation (effect sizes ≥0.14). 
Conclusion This study indicates that an acute dose of high-EPA fish oil may ameliorate the functional 
changes following EIMD. 
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Introduction 
Exercise-induced muscle damage (EIMD) is a well-recognised and documented condition, and 
primarily occurs as a result of unaccustomed or eccentrically biased exercise (Proske and Morgan 
2001). EIMD manifests through increases in localised inflammation, decreases in functional muscle 
capability and, most noticeably, through increases in perceived muscle soreness 24–72h following a 
damaging bout of exercise (Jakeman et al. 2009; Webb and Willems2010). These transient 
symptoms can be relatively debilitating, and while there may be positive long-term adaptations 
elicited as a result of EIMD, those involved in the preparation of athletes for competition, in 
particular multiple competitions in a short time frame, have sought methods of facilitating recovery 
to expedite a return to optimal performance. To this end, methods such as cold-water immersion, 
massage, and active recovery have been considered (Barnett 2006), although the evidence 
advocating the use of these treatments remains equivocal (Bailey et al. 2007; Jakeman et al. 2009; 
Hilbert et al. 2003). In addition, it has been demonstrated that exercise which results in muscle 
damage can confer a protective effect on an individual, known as the repeated bout effect, reducing 
symptoms from similar future exercise as long as the exercise bouts in each condition are similar 
(Margaritelis et al. 2015). 
While physical therapies have shown some success in alleviating the symptoms of EIMD, nutritional 
supplementation is also widely used to facilitate recovery following EIMD, with a number of studies 
considering the efficacy of non-steroidal anti-inflammatory drugs for example (Bourgeois et al. 1999; 
Paoloni et al. 2009). Omega-3 fish oil is a supplement which has increased in popularity as it has 
potent anti-inflammatory effects and is associated with a lower risk of coronary heart disease (Hu et 
al. 2002). The two primary constituents of fish oil, eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA), are thought to reduce the production and release of arachidonic acid and pro-
inflammatory prostaglandins, among others, with this being particularly true of EPA (Tartibian et al. 
2011; Lenn et al. 2002). Accordingly, it has been suggested that fish oil can ameliorate the symptoms 
of EIMD, including soreness and swelling (Jouris et al. 2011). Typically, prolonged supplementation 
periods, including 7, 21, 26 and 30 days, have been used to assess the effect of fish oil in moderating 
EIMD, as it has been demonstrated that chronic supplementation can result in EPA and DHA being 
incorporated into cellular membranes (Jouris et al. 2011; Houghton and Onambele 2012; 
Mickleborough et al. 2015; Lembke et al. 2014; Lenn et al. 2002). Recent research has concluded 
that EPA and DHA supplementation in a 2:1 ratio may be beneficial to attenuating symptoms of 
EIMD when consumed chronically (8 weeks; Tsuchiya et al. 2016). While these findings are of 
practical interest, anecdotal evidence suggests that individuals consume fish oil immediately 
postexercise in an attempt to ameliorate symptoms of EIMD. There is currently little evidence to 
support this approach. As such, research into the effects of acute supplementation, in respect to 
real-world practices, is warranted, particularly to guide the athletes and coaches intending to 
maximize recovery following strenuous exercise. 
The purpose of this study was, therefore, to examine the efficacy of an acute dose of omega-3 fish 
oil on recovery following EIMD. It was hypothesised that an acute dose of omega-3 fish oil would aid 
recovery following EIMD, and that a high dose of EPA would have a greater effect than a low dose of 
EPA. 
Methods 
Participants 
For this double-blind, placebo-controlled study, 27 physically active (>3h wk− 1 of vigorous athletic 
training involving repeated bouts of high-intensity intermittent training) men volunteered to 
participate (26 ± 4 year, 1.77 ± 0.07 m, 80 ± 10 kg). Participants were injury-free, healthy and 
asymptomatic of any illness, as confirmed through health screening procedures (ACSM 2013), and 
were excluded if they had engaged in specific lower limb eccentric or plyometric training in the 
previous 6 months. Volunteers were asked to refrain from any exhausting physical activity or from 
using any additional form of recovery method (e.g., ice, massage, nutritional supplements) in an 
attempt to attenuate the negative effects of EIMD during their participation in this study. The study 
was conducted in agreement with the policies and guidelines of the institutional Human Ethics 
Committee, and informed consent was obtained from all individual participants included in the 
study. A priori calculations of statistical power indicated that this sample size was appropriate to 
satisfy power at or above 80% (Jakeman et al. 2010). 
Procedures 
Following the collection of anthropometric data, participants completed an exercise protocol 
designed to induce muscle damage. Following this, participants were randomly assigned to one of 
the three groups: High EPA (n = 9; age 25.5 ± 5.2 years, height 1.74 ± 0.06 m, weight 76.5 ± 12.6 kg), 
Low EPA (n = 9; age 25.6 ± 4.8 years, height 1.82 ± 0.09 m, weight 80.2 ± 12.0 kg) or placebo (n = 9; 
age 26.2 ± 4.2 years, height 1.78 ± 0.01 m, weight 82.9 ± 12.1 kg). Physiological and perceptual 
characteristics were assessed in the following sequential order, prior to- [baseline (BL)] and following 
(1, 24, 48, 72 and 96 h) the EIMD protocol: myofibre protein concentration [plasma creatine kinase 
(CK)], inflammatory markers [Interleukin 6 (IL-6)], perceived muscle soreness, countermovement and 
squat jump height and isokinetic muscle strength (maximal knee extension). Data were collected 1 h 
after damaging exercise to provide an indicator of the magnitude of immediate muscle damage, 
without the confounding factor of acute fatigue resultant from the muscle-damaging protocol. 
Plyometric exercise protocol 
To induce muscle damage, participants performed 10 × 10 repetitions of plyometric drop jumps, 
with 10 s separating each jump, and 60-s recovery between sets, beginning after completion of the 
tenth jump of each set. Under the guidance of an experienced strength and conditioning coach, 
participants were asked to step from a 0.6-m-high box, land (with both feet) in a squat position, with 
approximately 90° of hip and knee flexion, and then perform a maximal vertical jump in a continuous 
movement. This protocol has been used successfully elsewhere (Highton et al. 2009). 
Randomisation 
On completion of the plyometric exercise protocol, participants were randomised into one of three 
groups: Con—participants received placebo capsules which consisted of filler oil, flavour masker and 
gelatine; High EPA—participants consumed 1g 10 kg body mass of fish oil capsules; EPA 750 mg, DHA 
50 mg; Low EPA—participants consumed 1g 10 kg body mass of fish oil capsules; EPA 150 mg, DHA 
100 mg. All supplements were provided in 1-g capsules, and given to participants in one dose upon 
completion of the plyometric protocol. Allocation to groups was by means of sealed envelopes 
drawn by the participants, designed for an equal allocation between the three groups. A researcher 
who was not involved in data collection provided capsules, while data analysts were blinded from 
the grouping code. 
Assessment of EIMD 
Jump performance 
Squat and countermovement jump height was assessed using a vaned jump and reach apparatus, 
which provides the maximum height reached to the nearest centimetre (Yardstick, Swift Systems, 
Lismore, Australia), with the best of three attempts being recorded in accordance with previous 
research (Ali et al. 2011; Pournot et al. 2011). Each jump was completed after verbal command and 
demonstration, with a minimum of one-minute between jumps, following the protocol of Jakeman 
et al. (2010). Participants were given time prior to beginning the experimental procedure to 
familiarise themselves with this apparatus and jump procedures. Typical CV% for these measures 
within our lab is 3–3.5% for these jumps. 
Isokinetic muscle strength 
Dynamic muscle function was assessed using isokinetic dynamometry. Participants were seated 
upright with the upper body and experimental leg secured to reduce extraneous movement. The 
axis of rotation of the knee of the dominant leg was aligned with the dynamometer which was 
maintained throughout the testing period. Each participant’s body position was recorded and 
replicated for subsequent tests. Participants completed five maximal voluntary isokinetic concentric 
contractions at 60° and 180° s−1 through approximately a 90° range of movement from 90° knee 
flexion on the dominant leg. The best of five maximal gravity-corrected concentric contractions 
(Biodex 3 Medical Systems, New York, USA) of the knee extensors was taken as the criterion 
measure of muscle strength. 
Perceived muscle soreness 
Perceived soreness was assessed using a 10-cm visual analogue scale, with 0 (no pain) and 10 (worst 
pain ever) at the two extremes. Participants were instructed to assume an unweighted squat of 
approximately 90° and mark their perceived soreness on a horizontal line between 0 and 10 (Twist 
and Eston 2005). 
Blood markers 
A 6-ml venous blood sample was drawn from the antecubital vein at each time point, and was 
centrifuged (Medifuge, Heraeus Sepatech, Germany) for 10 min to obtain plasma samples (Woolley 
et al., 2014), which were frozen at −80 °C until analysis. Automated spectrophotometry (Cobas 6000, 
Roche Diagnostics, Indianapolis, USA) was used to analyse samples for plasma CK concentration, and 
an ELISA kit (Enzyme-Linked Immuno-Sorbent Assays, Enzo Life Sciences, New York, USA) with a 
sensitivity of 6.01 pg·ml and specific for bioactive human IL-6 was used to measure interleukin-6. 
Statistical analysis 
Data for creatine kinase and IL-6 were log-transformed to address assumptions of sphericity, and all 
performance data were analysed as a proportion of baseline (%). A series of two-factor repeated-
measures analysis of variance; Group (High EPA, Low EPA, Con) by Time (BL, 1, 24, 48, 72, and 96 h) 
were used to analyse data. The Mauchly sphericity test was used to test assumptions of 
homogeneity of variance. If this was violated, the Greenhouse–Geisser value was used to adjust 
degrees of freedom to increase the critical value of the F ratio. Effect sizes were reported as partial 
eta-squared (η2 p), whereby 0.01, 0.06 and 0.14 represented a small, medium and large effect 
(Cohen 1988). Alpha was set at 0.05 throughout all analyses, and all data were analysed using the 
statistical package SPSS for Windows, PC 
Results 
Jump performance 
A significant main effect for Time was observed for both squat jump (F3,77 = 14.4, p < 0.001, η2 p = 
0.38) and countermovement jump performance (F2.9,70 = 10.5, p < 0.05, η2 p = 0.31), whereby the 
significant decreases in performance which were observed at 1 h were maintained until 96 h post-
EIMD (Fig. 1). A significant Group effect was also observed for Squat jump performance (F2,24 = 7.5, 
p < 0.05, η2 p = 0.39), with the High EPA group performing significantly better than either the Low 
EPA or Con groups. Although non-significant, a similar trend was observed for countermovement 
jump performance (F2,24 = 3.19, p = 0.07, η2 p = 0.2). There was no Group x Time interaction for 
either squat- or countermovement jump performance (p > 0.05); however, a large effect was 
observed (both eta = 0.13). 
Isokinetic muscle strength 
A significant Time main effect was observed for knee extensor strength at both 60° s−1 (F5,120 = 
25.7, p < 0.05, η2 p = 0.52) and 180° s−1 (F5,120 p < 0.05, η2 p = 0.42; Fig. 2). There was a significant 
reduction in strength at 1 h at both 60° and 180° s−1, which persisted for 96 and 72 h, respectively, 
following damaging exercise. There were no differences between Groups (F2,24 = 1.9, p > 0.05, η2 p 
= 0.14; F2,24 = 0.4, p > 0.05, η2 p = 0.31 for 60° and 180° s− 1, respectively), nor any Group by Time 
interactions (F10,120 = 1.5, p > 0.05, η2 p = 0.11 and F10, 120 = 0.62, p > 0.05, η2 p = 0.05 for 60° 
and 180° s−1, respectively).  
Perceived muscle soreness 
There was a significant main effect for Time (F2.5, 60.5= 36.6, p < 0.05, η2 p = 0.60), but no Group 
(F2,24 = 0.69, p > 0.05, η2 p = 0.05) or Group × Time interaction (F5, 60.5 = 1.05, p > 0.05, η2 p = 
0.08). In all Groups, perceived soreness peaked at 24 h following EIMD, and recovered to baseline 
values at 96 h (Fig. 3). 
Myofibre proteins 
There was a significant Time main effect for creatine kinase concentration (F1.6,36 = 13.9, p < 0.05, 
η2 p = 0.38), but no Group or Group × Time interaction (F2,22 = 1.6, p > 0.05, η2 p = 0.12 and F3.2,36 
= 0.143, p > 0.05, η2 p = 0.13, respectively). There were no Time (F2.2,41.8 = 1.04, p > 0.05, η2 p = 
0.052), Group (F2,22 = 0.225, p > 0.05, η2 p = 0.12) or Group × Time interaction effects (F3.2,36 = 
0.143, p > 0.05, η2 p = 0.013) for IL-6 following EIMD (Table 1). 
Discussion 
This study assessed whether an acute dose of omega-3 fish oil immediately following strenuous, 
eccentrically biased exercise would moderate symptoms of EIMD. The current study shows that 
acute ingestion of omega-3 fish oil, in particular a supplement which is high in EPA, is beneficial to 
some markers of exercise performance following EIMD, in comparison with either a low-dose EPA 
supplement, or a placebo. While many studies have investigated the efficacy of omega-3 fish oil as a 
recovery strategy following EIMD, to our knowledge, this is the first study to consider a large, acute 
dose of omega-3 in such a manner. To facilitate the practical applicability of the current work and 
descriptive usefulness, we have included both effect sizes and confidence intervals relating to the 
collected data (Richardson 2011). While statistical significance is important, in studies with small 
sample sizes such as those often seen in the sport and exercise science area, consideration of the 
magnitude of effect is sometimes more useful for the full evaluation of data (Rhea 2004). 
It is well established that physical performance is detrimentally effected by EIMD, with a number of 
studies showing reductions in peak power generation, jump performance and time trial exercise 
(Byrne and Eston 2002; Twist and Eston 2005; Burt and Twist 2011). Consistent with our hypothesis 
as indicated in Fig. 1a, and when observing a large effect size (η2 p = 0.39), high-dose EPA 
supplementation attenuated the decrement in average squat jump performance (−2.1%) in 
comparison to both low-dose EPA (−9.8%) and placebo (−8.3%) supplementation. Importantly, 
participants in the High EPA group had recovered to within ~2% of baseline performance at 24 h, 
whereas participants in the Low EPA or Con groups remained ~12% lower than baseline performance 
at 24 h. From a practical perspective, the impairment in squat jump performance at 1 h in the High 
EPA group was equivalent to the impairment observed at 96 h for both the Low EPA and placebo 
groups, indicating a faster recovery of performance capability. A similar pattern was also observed 
with countermovement jump performance (average decrement of 1.7, 6.8, and 6.8% in High EPA, 
Low EPA and Con, respectively; η2 p = 0.2). For example, the decrement in performance was only 4% 
after 1 h for the High EPA group in comparison with the 10.1 and 15% decrements observed for the 
Con or Low EPA groups, respectively. Similar to the changes in squat jump performance, the High 
EPA group returned to within 2% of baseline performance after 24 h, in comparison with the Control 
and Low groups, whereby there countermovement jump performance was still 4.4 and 3.8% below 
baseline at their 96 h re-assessment (Fig. 1b). 
It is widely agreed that one of the initial consequences of EIMD is harm to the contractile machinery 
of the muscle, manifest by the disruption of sarcomeres, which is thought to prevent the muscle 
from contracting normally (Proske and Morgan 2001). Squat jump exercise relies heavily on muscle 
contractile properties by limiting as much as possible, the influence of the stretch–shortening cycle. 
Therefore, reductions in squat jump performance are likely to be related to an inability to contract 
musculature due to the bout of damaging exercise. Reductions in contractile force capability are 
compounded by the possibility that voluntary muscle activation is negatively affected by EIMD 
(Prasartwuth et al. 2005). However, Prasartwuth et al. (2005) suggest that reductions in maximal 
voluntary muscle activation may be a partial cause of initial force loss. The countermovement jump 
in this case relies on the influence of the stretch–shortening cycle, as well as the contractile 
machinery, and therefore, changes in neural factors are likely to have a compounding effect on 
performance. With the current data showing an immediate protective effect in the High group, it is, 
therefore, possible that supplementation allowed for greater voluntary activation, a suggestion 
supported by Lewis et al. (2015). In their study, although their findings were not in relation to EIMD, 
Lewis and colleagues reported that peripheral neuromuscular function may be improved in 
experimental athletic situations as a result of consumption of omega-3. 
When considering the isokinetic muscle function at 60° and 180° s−1, despite no statistical 
differences between groups, large effect sizes were noted (0.14 and 0.31, respectively). Average 
performance changes at 60° and 180° s−1 were similar to changes in the squat and countermovement 
jump, respectively, and may reflect similar speed characteristics between these measures. Again, 
changes in performance at 60° s−1 are likely to be due to a reduced ability of the contractile 
machinery used at this relatively slow movement speed. The pattern of change in performance at 
180° was similar in all groups, and while there was no statistically significant difference in group, 
there is a trend toward a protective effect at 60° s−1. The large effect sizes, here, indicate that for 72 
h after damaging exercise, individuals in the High group seemed to experience a lower reduction in 
performance (Fig. 2). It is worth noting that isokinetic muscle function was analysed concentrically, 
to be more relevant to the prime mover muscles involved in many sporting activities, such as 
running and jumping (McBride et al. 2008). However, it is possible that the eccentric damaging 
protocol would have been more pronounced on an eccentric isokinetic movement pattern, and 
given that eccentric muscle movements are imperative for movement stability (LeStayo et al. 2003), 
future studies may find it interesting to consider eccentric muscle function assessment, in place of or 
in addition to concentric muscle function assessment, particularly where injury is a primary topic of 
interest. 
One of the most noticeable effects of EIMD is delayed onset muscle soreness (DOMS), which may be 
associated with an increase in swelling resulting from the bout of damaging exercise (Miller et al. 
2004). While this is a normal process of recovery and adaptation within the body, symptoms of EIMD 
such as DOMS are detrimental to performance in athletic situations. While there is benefit to 
physical activity which results in EIMD (see McHugh 2003 for example), individuals involved in 
regular and repeated competition in a short time period (i.e., tournament play) may wish to forgo 
any positive adaptive effects in favour of being able to maintain optimal athletic performance. As a 
result of studies demonstrating an anti-inflammatory effect of omega-3 (Tartibian et al. 2011; 
Mickleborough et al. 2015), it was hypothesised that IL-6, and perceived muscle soreness may have 
been reduced in the High and Low EPA groups. Although not conclusive (Weldon et al. 2007), EPA 
has been shown to be a more potent inhibitor of the inflammatory response than DHA 
(Mickleborough et al. 2009), and it may have been expected that this would result in the High EPA 
group having reduced symptoms of inflammatory markers. Such findings were not evident in the 
present study as similar perceptions of muscle soreness and inflammatory markers were observed 
between groups. While this is in contrast to other studies which have considered similar scenarios 
(Jouris et al. 2011), the lack of impact on perceived muscle soreness reflects the work by Lenn et al. 
(2002) and Houghton and Onambele (2012). It is likely that the lack of effect in the current work was 
due to the nature of the supplementation, in the fact that it was an acute, rather than a chronic 
supplementation protocol. Prolonged ingestion of omega-3 fish oil has been shown to result in 
changes to muscle cell membrane, altering its permeability and making the cell less susceptible to 
EIMD. Tartibian et al. (2009), for example, reported reduced perceived soreness following strenuous 
eccentric exercise in a group supplemented for 30 days with omega-3. The authors suggested that 
this may be due to a decrease in muscle damage or reduction in inflammation experienced by the 
supplementing group, in comparison with both a placebo group, and a non-supplementing control, 
and is a theme which has been reported elsewhere (Tsuchiya et al. 2016). Given that the current 
study employed an acute dose of omega-3, it may have had little effect on inflammatory markers 
immediately after damaging exercise, but may have been influential in promoting recovery at later 
time points. Previous research by Gingras et al. (2007) has indicated that ingestion of omega-3 oils 
can alter protein synthesis and insulin sensitivity, and positive alterations in anabolic responses have 
also been reported by Smith et al. (2011a, b) in human models. This suggests that omega-3 fatty 
acids can stimulate muscle protein synthesis, which may also have influenced the recovery process; 
however, further study would be required to determine this. Although there were no indications 
that inflammatory markers had been affected by the treatment, it is worth noting that some 
inflammatory markers, particularly creatine kinase, relate poorly to the magnitude or time course of 
EIMD as indicated by other markers (for review, see Warren et al. 1999). While not measured, it is 
possible that swelling of the affected limbs may have been reduced by the treatment and, therefore, 
contribute to the differences in the response observed on the performance measures. 
As noted previously, the supplementation strategy used in the current study is very different to that 
used by others, in that it focuses on an acute, large dose supplementation. Recently, Tsuchiya et al. 
(2016) investigated the use of a ratio of EPA:DHA of approximately 2:1, with participants ingesting 
600 mg EPA and 260 mg DHA each day for 8 weeks. Participants in the current study consumed 
either 15:1 or 1.5:1 EPA:DHA ratio immediately after EIMD, which was relativised for body mass, an 
important consideration which has also not been previously made. While it appears that the High 
group (15:1 EPA:DHA) experienced an enhanced recovery, the mechanisms responsible for this were 
not investigated in the current study, and should be considered in future work. As a result of the 
novel dosing strategies (an acute dose relative to body mass), it makes the comparison of the 
current results with other similar studies problematic, and further research on the areas of dose, 
duration and body mass/composition should be considered. 
Conclusions 
In conclusion, this double-blind, placebo-controlled study has demonstrated that a high dose of high-
EPA omega-3 fish oil immediately following strenuous, eccentrically biased exercise may moderate 
symptoms of EIMD. While statistically non-significant, the large effect sizes observed suggest that a 
number of the considered performance measures were positively influenced by the High but not the 
Low EPA dose. During both the squat and countermovement jump, the performance decrement in 
those individuals taking the high-dose omega-3 fish oil was significantly attenuated, nearly returning 
to their baseline level of performance within 24 h. While these findings are of practical interest, 
further research is needed to determine optimal supplementation strategies, both in terms of 
duration and dose, as well as the optimal EPA:DHA ratio. 
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Table 1 Creatine kinase and IL-6 concentration before and up to 96h after damaging exercise 
Data presented as mean (±sd) 
Time        
 Condition Baseline 1h 24h 48h 72h 96h 
CK (u.L)   A 189.1 (116.2) 229.2 (126.5) 419.1 (194.8) 278.4 (120.5) 195.0 (79.3) 216.3 (153.5) 
 B 311.1 (200.8) 372.0 (189.2) 627.3 (451.1) 457.6 (401.6) 430.1 (577.2) 401.4 (538.9) 
 C 182.3 (123.0)        232.6 (124.1) 450.4 (286.6) 266.4 (120.5) 204.9 (110.1) 164.8 (69.0) 
        
IL-6 (pg/ml)          A 7951.1 (3684.3) 8195.7 (3812.0) 8179.3 (3680.1) 8103.3 (3794.3) 8059.8 (3553.9) 8092.4 (3559.9) 
 B 5528.0 (2882.5) 5534.2 (2533.9) 5751.6 (2944.1) 5528.0 (2315.7) 5254.7 (2139.4) 5652.2 (2600.2) 
 C 6267.1 (2525.2) 5913.1 (1766.5) 5472.0 (2216.7)  5484.5 (1912.8) 5130.4 (2070.4) 5987.6 (2765.9) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig. 1 Squat (a) and countermovement (b) jump performance before and up to 96h after damaging 
exercise. *Denotes a significant group effect 
Fig. 2 Isokinetic muscle strength at 60° s−1 (a) and 180° s−1 (b) before and up to 96h after damaging 
exercise 
Fig. 3 Perceived muscle soreness before and up to 96 h after damaging exercise 
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